CH504426A - Verfahren zur Herstellung neuer Bisnorcholanderivate - Google Patents
Verfahren zur Herstellung neuer BisnorcholanderivateInfo
- Publication number
- CH504426A CH504426A CH1249169A CH1249169A CH504426A CH 504426 A CH504426 A CH 504426A CH 1249169 A CH1249169 A CH 1249169A CH 1249169 A CH1249169 A CH 1249169A CH 504426 A CH504426 A CH 504426A
- Authority
- CH
- Switzerland
- Prior art keywords
- bisnorcholane
- derivatives
- new
- production
- new bisnorcholane
- Prior art date
Links
- 150000001623 bisnorcholanes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DESC037674 | 1965-09-03 | ||
DESC038090 | 1965-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH504426A true CH504426A (de) | 1971-03-15 |
Family
ID=25993310
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1254366A CH504425A (de) | 1965-09-03 | 1966-06-30 | Verfahren zur Herstellung neuer Bisnorcholanderivate |
CH1249169A CH504426A (de) | 1965-09-03 | 1966-08-30 | Verfahren zur Herstellung neuer Bisnorcholanderivate |
CH1249269A CH505805A (de) | 1965-09-03 | 1966-08-30 | Verfahren zur Herstellung neuer Bisnorcholanderivate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1254366A CH504425A (de) | 1965-09-03 | 1966-06-30 | Verfahren zur Herstellung neuer Bisnorcholanderivate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1249269A CH505805A (de) | 1965-09-03 | 1966-08-30 | Verfahren zur Herstellung neuer Bisnorcholanderivate |
Country Status (5)
Country | Link |
---|---|
US (1) | US3539687A (de) |
CH (3) | CH504425A (de) |
DE (2) | DE1493169A1 (de) |
GB (1) | GB1118976A (de) |
NL (1) | NL6612348A (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4088760A (en) * | 1976-06-23 | 1978-05-09 | Richardson-Merrell Inc. | Testosterone 5α-reductase inhibitors |
DE2839033A1 (de) * | 1978-09-05 | 1980-03-13 | Schering Ag | 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung |
AT368759B (de) * | 1980-05-12 | 1982-11-10 | Henkel Kgaa | Verfahren zur herstellung von neuen steroid-20carbons[ureverbindungen |
US5380841A (en) * | 1985-09-12 | 1995-01-10 | The Upjohn Company | Pyridinylpiperazinyl steroids |
US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
USRE35053E (en) * | 1985-09-12 | 1995-10-10 | The Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
US20100047338A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
CN102686600A (zh) * | 2009-02-05 | 2012-09-19 | 托凯药业股份有限公司 | 甾体cyp17抑制剂/抗雄激素物质的新型药物前体 |
CA2904170A1 (en) | 2013-03-14 | 2014-09-25 | University Of Maryland, Baltimore | Androgen receptor down-regulating agents and uses thereof |
CN105636594A (zh) | 2013-08-12 | 2016-06-01 | 托凯药业股份有限公司 | 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2697107A (en) * | 1951-06-20 | 1954-12-14 | Hoechst Ag | Process of preparing chloramines of the steroid series |
US2886564A (en) * | 1955-03-24 | 1959-05-12 | Upjohn Co | Quaternary steroidal enamine salts |
US3038912A (en) * | 1961-07-21 | 1962-06-12 | Searle & Co | 20(bets)-[(monoalkylamino)methyl]pregn-5-en-3beta-ols, esters corresponding and intermediates thereto |
GB1095167A (en) * | 1963-12-05 | 1967-12-13 | Shalom Sarel | Amino-steroids |
-
1965
- 1965-09-03 DE DE19651493169 patent/DE1493169A1/de active Pending
- 1965-11-27 DE DE19651493181 patent/DE1493181A1/de active Pending
-
1966
- 1966-06-30 CH CH1254366A patent/CH504425A/de not_active IP Right Cessation
- 1966-08-30 US US576158A patent/US3539687A/en not_active Expired - Lifetime
- 1966-08-30 CH CH1249169A patent/CH504426A/de not_active IP Right Cessation
- 1966-08-30 CH CH1249269A patent/CH505805A/de not_active IP Right Cessation
- 1966-09-01 NL NL6612348A patent/NL6612348A/xx unknown
- 1966-09-02 GB GB39326/66A patent/GB1118976A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH505805A (de) | 1971-04-15 |
GB1118976A (en) | 1968-07-03 |
DE1493181A1 (de) | 1969-06-26 |
US3539687A (en) | 1970-11-10 |
DE1493169A1 (de) | 1969-06-04 |
NL6612348A (de) | 1967-03-06 |
CH504425A (de) | 1971-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH513111A (de) | Verfahren zur Herstellung neuer Benz-epinderivate | |
CH474486A (de) | Verfahren zur Herstellung neuer Diphenylharnstoffe | |
CH526579A (de) | Verfahren zur Herstellung neuer Benziodoxanderivate | |
CH504426A (de) | Verfahren zur Herstellung neuer Bisnorcholanderivate | |
AT279636B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate | |
CH519488A (de) | Verfahren zur Herstellung neuer 19-Nor-androstatriene | |
CH476723A (de) | Verfahren zur Herstellung neuer Isoindol-Derivate | |
CH467786A (de) | Verfahren zur Herstellung neuer Chinazolin-Derivate | |
CH467789A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
CH432538A (de) | Verfahren zur Herstellung neuer Yohimban-Derivate | |
CH517737A (de) | Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate | |
AT256848B (de) | Verfahren zur Herstellung neuer Oxepinderivate | |
AT256097B (de) | Verfahren zur Herstellung neuer Indolderivate | |
CH467800A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
CH473807A (de) | Verfahren zur Herstellung neuer 4-Hydroxy-chinoline | |
AT310962B (de) | Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate | |
CH462834A (de) | Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate | |
CH464935A (de) | Verfahren zur Herstellung neuer Chinazolinonderivate | |
CH467779A (de) | Verfahren zur Herstellung neuer Indol-Derivate | |
CH468386A (de) | Verfahren zur Herstellung neuer Ergolen-Derivate | |
AT261819B (de) | Verfahren zur Herstellung neuer Gonanderivate | |
CH467793A (de) | Verfahren zur Herstellung neuer Ergolen-Derivate | |
AT266106B (de) | Verfahren zur Herstellung neuer Nitrofuranderivate | |
AT243813B (de) | Verfahren zur Herstellung neuer Azepinderivate | |
CH451924A (de) | Verfahren zur Herstellung neuer Indanderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |